Scientific work

Prof. Dr. Deniz Arslan

91 publications. The source of the information is stated next to each publication.

Back to profile

  1. A1. D. Arslan, D. Tural, T. Koca, D. Tastekin, A.K. Cerkesli, H. Başaran, S. Gunduz, A.M. Tatli, S.S. Goksu, M. Uysal, A. Kargi, B. Kargi, L. Koral, C.İ. Bassorgun, D. Unal, H. Mutlu, H.S. Coskun, M. Ozdogan, H. Bozcuk (2015). Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer. Journal of Balkan Union of Oncology, 2015:20(2):573-579. Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  2. A2. D. Arslan, T. Koca, D. Tastekin, H. Başaran, H. Bozcuk (2014). Impact of poster presentations on academic knowledge transfer from the oncologist perspective in Turkey. Asian Pac J Cancer Prev. 2014;15(18):7707-11. Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  3. A3. D.Arslan, H.Bozcuk, S.Gunduz, D.Tural, A.M.Tatli, M.Uysal, S.S.Goksu, C.İ.Bassorgun, L.Koral, H.S.Coskun, M.Ozdogan, B.Savas. Survival Results and Prognostic Factors in T4 N0-3 Non-small Cell Lung Cancer Patients According to the AJCC 7th Edition Staging System (2014). Asian Pacific Journal of Cancer Prevention, Asian Pac J Cancer Prev. 2014;15(6):2465-72. Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  4. A4. D. Arslan, D. Tural, E. Akar. Herbal Administration and İnteraction of Cancer Treatment (2013). JOURNAL OF PALLİATİVE MEDİCİNE. 2013 Nov;16(11):1466-76. Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  5. A5.. D. Arslan, A. Merdin, D. Tural, M. Temizel, O. Akın , S. Gündüz, AM Tatlı, F. Avcı, M. Uysal. The effect of autoimmunity on the development time of microvascular complications in patients with type 1 diabetes mellitus. Medical Science Monitor. 2014 Jul 10;20:1176-9. Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  6. A6. D. Arslan, S.Gündüz, D.Tural, M.Uysal, A.M.Tatlı, C.Başsorgun, G.Elpek, H.S.Coşkun, H.Bozcuk, B.Savaş. Inflammatory myofibroblastic tumor: a rarely seen submucosal lesion of the stomach (2013). Case Reports in Oncological Medicine. 2013;2013:328108. İlgili atıf indekslerince taranıyor.

    Source: medicana.com.tr profile page

  7. A7. D. Arslan, M. Uysal, A.M. Tatlı, S. Gunduz, S.S. Goksu, C.İ. Bassorgun, H.S. Coskun, H. Bozcuk (2014). Her-2 Positive Gastric Cancer Presented with Thrombocytopenia and Skin Involvement: A Case Report. Case Reports in Oncological Medicine. 2014;2014:194636. İlgili atıf indekslerince taranıyor.

    Source: medicana.com.tr profile page

  8. A8. D. Arslan, D. Tural, AM. Tatlı, E. Akar, M. Uysal, G. Erdoğan. Isolated uterine metastasis of invasive ductal carcinoma (2013). Case Reports in Oncological Medicine. 2013;2013:793418. İlgili atıf indekslerince taranıyor.

    Source: medicana.com.tr profile page

  9. A9. D. Arslan, S. Gündüz, F. Avci, A. Merdin, A.M. Tatli, M. Uysal, D. Tural, C.İ. Bassorgun, B. Savas. Pilomatrix carcinoma of the scalp with pulmonary metastasis: A case report of a complete response to oral endoxan and etoposide (2014). Oncology Letters, 7(6), 1959-1961. Endeks: SCI-Expanded.

    Source: medicana.com.tr profile page

  10. A10. D.Arslan, F.Avcı, A.Merdın, S.Gunduz, H. S. Coskun. Management of a patient with colon cancer and rotor syndrome: A case report (2013). Oncology Letters. 2014 Mar;7(3):797-798. Endeks: SCI-Expanded.

    Source: medicana.com.tr profile page

  11. A11. M. Uysal, H. Bozcuk, S. Goksu, A. M. Tatli, D. Arslan, S. Gunduz, H. S. Coskun, M. Ozdogan, B. Savas, "Basal proteinuria as a prognostic factor in patients with metastatic colorectal cancer treated with bevacizumab", Biomedicine & Pharmacotherapy, "14", 4-8 pp., Mart-2014, doi: 10.1016/j.biopha.2014.03.002, Endeks: SCI

    Source: medicana.com.tr profile page

  12. A12. D. Tural, O. Eliçin, Ş. Batur, D. Arslan, B. Öz, S. Serdengecti, Ö. Uzel, ’’Human papillomavirus is independent prognostic factor on outcome of oropharyngeal squamous cell carcinoma’’, Tumor Biology, 2013, 34:3363-3369, DOI 10.1007/s13277-013-0907-8, Endeks: SCI

    Source: medicana.com.tr profile page

  13. A13. D. Tural, O. Elicin, S. Batur, D. Arslan, B. Öz, S. Serdengecti, O. Uzel, ’’Increase in the Rate of HPV Positive Oropharyngeal Cancers During 1996-2011 in a Case Study in Turkey’’, ’’14’’, 6065-6068 pp., 2013, Asian Pacific Journal of Cancer Prevention, DOI:http://dx.doi.org/10.7314/APJCP.2013.14.10.6065, Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  14. A14. M.Uysal, H.Bozcuk, H.Karakılınç, S.Goksu, A.M.Tatli, S.Gunduz, D.Arslan, H.S.Coskun, B.Savas, "Pesticides and Cancer: The First Incidence Study Conducted in Turkey", Journal of Environmental Pathology, Toxicology and Oncology, "32", 245-249 pp., Ekim-2013, DOI: 10.1615/JEnvironPatholToxicolOncol.2013008232, Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  15. A15. D.Arslan, Ş.Gündüz, F.Avcı, A.Merdin, A.M.Tatli, M.Uysal, D.Tural, C.I.Başsorgun, B.Savaş, "Pilomatrix carcinoma of the scalp with pulmonary metastasis: A case report of a complete response to oral endoxan and etoposide", Oncology Letters, "7", 1959-61 pp., Haziran-2014, DOI: 10.3892/ol.2014.2021, Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  16. A16. S.Gunduz, G.O.Elpek, M.Uysal, S.S.Goksu, M.Tatli, D.Arslan, H.S.Coskun, H.Bozcuk, B.Savas, O.Ozdogan., "Coexistence of gastric adenocarcinoma and choriocarcinoma: complete response to trastuzumab and chemotherapy", Case Rep Oncol, "5", 394-9 pp., Mayıs-2012, İlgili atıf indekslerince taranıyor.

    Source: medicana.com.tr profile page

  17. A17. A.M.Tatlı, S.Gunduz, S.S.Göksu, D.Arslan, M.Uysal, C.Başsorgun, H. S. Coşkun., "Dystrophic Cutaneous Calcification and Metaplastic Bone Formation due to Long Term Bisphosphonate Use in Breast Cancer", Case Reports in Oncological Medicine, "2013", Temmuz-2013, DOI: 10.1155/2013/871917, İlgili atıf indekslerince taranıyor.

    Source: medicana.com.tr profile page

  18. A18. A.M.Tatli, M.Uysal, S.S.Goksu, D.Arslan, S.Gunduz, M.Ozdogan, H.S.Coskun, H.Bozcuk, B.Savas., "Primary mucinous adenocarcinoma of the bladder: complete response with FOLFOX-4 regimen", Med Oncol, "29", 1935-7 pp., Eylül-2012, doi: 10.1007/s12032-011-0090-y Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  19. A19. A.M.Tatli, M.Uysal, S.S.Goksu, S.Gunduz, D.Arslan, M.Ozdogan., "Complete Response of Primary Bladder Adenocarcinoma with the FOLFOX4 Regimen", Urologia Internationalis, Kasım-2013, DOI: 10.1159/000354332, İlgili atıf indekslerince taranıyor.

    Source: medicana.com.tr profile page

  20. A20. D. Arslan, T. Koca, D. Tastekin, H. Basaran, H. Bozcuk. ’’Impact of Poster Presentations on Academic Knowledge Transfer from the Oncologist Perspective in Turkey’’, Asian Pacific Journal of Cancer Prevention, ’’15’’, 7707-7711 pp., 2014, DOI:http://dx.doi.org/10.7314/APJCP.2014.15.18.7707, Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  21. A21. D. Arslan, D.Tural, T. Koca, D.Taştekin, A. K. Çerkeşli, H. Başaran, Ş. Gündüz, A.M.Tatlı, S. S. Göksu, M. Uysal, A. Kargı, B.Kargı, L. Koral, C. İ. Başsorgun, D. Ünal, H. Mutlu, H. Ş. Coşkun, M. Özdoğan, H. Bozcuk. ’’ Prognostic Factors in Clinical Stage T4N2 Locally Advanced Non-small Cell Lung Cancer’’, J BUON, vol.20,no.2,2015 issue,

    Source: medicana.com.tr profile page

  22. A22. D. Arslan, A. Merdin, D.Tural, M. Temizel, O. Akın, Ş. Gündüz, A.M.Tatlı, F. Avcı, M. Uysal. ’’The effect of autoimmunity on the development time of microvascular complications in patients with type 1 diabetes mellitus’’, Medical Science Monitor, e-ISSN 1643-3750, 2014; 20:1176-1179, DOI: 10.12659/MSM.890742, Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  23. A23. D. Tastekin, M. Tambas, K. Kilic, K. Erturk, D. Arslan. ’’The efficacy of Pistacia Terebinthus soap in the treatment of cetuximab-induced skin toxicity’’. İnvest New Drugs. 2014. Phase II Studies. DOI 10.1007/s10637-014-0128-z. Endeks: SCI

    Source: medicana.com.tr profile page

  24. A24. A.M. Tatli, D. Arslan, M. Uysal, S. S. Göksu, Ş.G. Gunduz, H. Ş. Coşkun, M. Özdoğan, B. Savas, H. Bozcuk. ’’Retrospective analysis of third-line chemotherapy in advanced non-small lung cancer’’. Journal of Cancer Research and Therapeutics. Kabul edildi, Basılacak. Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  25. A25. A.M. Tatli, H. Ş. Coşkun, M. Uysal, D. Arslan, S. S. Göksu, Ş.Gunduz, S. Çakal, H. Bozcuk, B. Savas. ’’Treatment with capecitabine+bevacizumab following induction treatment with FOLFİRİ+bevacizumab in metastatic colorectal carcinoma’’. Int J Clin Exp Med, 2014;7(8):2191-2196. www.ijcem.com /ISSN:1940-5901/IJCEM0001214. Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  26. A26. S.S. Goksu, S. Gunduz, D. Unal, M.Uysal, D. Arslan, A.M. Tatli, H.Bozcuk, M. Ozdogan, H.S. Coskun. ’’Use of Blood Transfusion at the End of Life: Does it Have Any Effects on Survival of Cancer Patients?’’, Asian Pac J Cancer Prev, "15", 4251-54 pp., Mart-2014, DOI:http://dx.doi.org/10.7314/APJCP.2014.15.10.4251, Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  27. A27. M. Uysal, M. Ozdogan, A. Kargi, S. Gunduz, S.S. Goksu, A.M. Tatli, D. Arslan, H. Mutlu, H.S. Coskun, H. Bozcuk. Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer, J BUON, “19”, .pp., Ekim 2014’te basılacak, Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  28. A28. S. Gunduz, H.S. Coskun, D. Arslan, S.S. Goksu, A.M. Tatli, M. Uysal, M. Ozdogan, B. Savas. ’’Can positron emission tomography-computed tomography predict response in locally advanced rectal cancer patients treated with induction folinic acid and 5-florouracil?’’, Indian Journal of Cancer, “51”, 138-41 pp., Ağustos-2014, doi: 10.4103/0019-509X.138234, Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  29. A29. S.S. Goksu, D. Tastekin, D. Arslan, S. Gunduz, A.M. Tatli, D. Unal, D. Salim, T. Guler, H.S. Coskun. ’’Clinicopathologic Features and Molecular Subtypes of Breast Cancer in Young Women (Age≤35)’’, Asian Pac J Cancer Prev, "15", 6665-68 pp., 2014, DOI:http://dx.doi.org/10.7314/APJCP.2014.15.16.6665, Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  30. A30. D. Tastekin, S. Kargin, M. Karabulut, N. Yaldız, M. Tambas, N. Gurdal, A.M. Tatlı, D. Arslan, A.F.K. Gok, F. Ayhan. ’’Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients’’. Tumor Biol. August 2014. DOI 10.1007/s13277-014-2429-4. Endeks: SCI

    Source: medicana.com.tr profile page

  31. A31. T. Koca, H. Basaran, D. Sezen, S. Karaca, Y. Ors, D. Arslan, A. Aydın.’’Comparison of Linear Accelerator and Helical Tomotherapy Plans for Glioblastoma Multiforme Patients’’, Asian Pacific Journal of Cancer Prevention, ’’15’’, 7811-16 pp., 2014, DOI:http://dx.doi.org/10.7314/APJCP.2014.15.18.7811, Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  32. A32. S. Gunduz, H. Mutlu, S.S. Goksu, D. Arslan, A.M. Tatli, M. Uysal, H.S. Coskun, H. Bozcuk, M. Ozdogan, B. Savas. ’’Oral Cyclophosphamide and Etoposide in Treatment of Malign Pleural mesothelioma’’, Asian Pac J Cancer Prev, Kabul edildi, Basılacak, Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  33. A33. S. Gunduz, H. Bozcuk, M. Yıldız, S.S. Goksu, M. Uysal, D. Arslan, A.M. Tatli, H. Mutlu, H.S. Coskun, M. Ozdogan. ’’Line of abiraterone acetate in castration-resistant metastatic prostate cancer – does it matter? Report of a multi-institutional experience’’, Indian Journal of Cancer, Kabul edildi, Basılacak. Endeks: SCI-Expanded

    Source: medicana.com.tr profile page

  34. A34. D. Arslan, M. Uysal, A.M. Tatli, S. Gunduz, S.S. Goksu, C.E. Bassorgun, H.S. Coskun, H. Bozcuk, B. Savas. ’’Her-2 Positive Gastric Cancer Presented with Thrombocytopenia and Skin Involvement: A Case Report’’, Case Reports in Oncological Medicine, “2014”, 1-5 pp., Haziran-2014, http://dx.doi.org/10.1155/2014/194636, İlgili atıf indekslerince taranıyor

    Source: medicana.com.tr profile page

  35. A35. T. Koca, H. Basaran, D. Arslan, D. Sezen, Z.A. Çerkeşli, Ö.Kılınç, S. Karaca, C.İ. Başsorgun, H.Ö. Okay, M. Demirci.’’Prominent response with helical tomotherapy in recurrent ameloblastic carcinoma of maxillary sinus: a case report’’, RADIATION ONCOLOGY,2014,9:157, Endeks: SCI- Expanded

    Source: medicana.com.tr profile page

  36. A36. A.M. Tatlı, A.A. Besen, M.E. Kalender, M. Uysal, D. Arslan, S.S. Göksu, S.G Gündüz, H.S. Coşkun. ’’Association of Vitiligo and Response in Patients with Metastatic Malignant Melanoma on Temozolomide’’, Tumori, Kabul edildi, Basılacak. İlgili atıf indekslerince taranıyor

    Source: medicana.com.tr profile page

  37. B1. D.Arslan, H.Bozcuk, A.M.Tatlı, S.Gündüz, M.Uysal, S.S.Goksu, L. Koral, D.Tural, H.S.Coşkun, B.Savaş, 2013 ASCO Annual Meeting Konferansı Dahilinde, Bildiri Kitapçığındaki " Survival Results and Prognostic Factors in T4 N0-3 Non-small Cell Lung Cancer Patients According to the AJCC 7th Edition Staging System ", 18517 pp., Chicago, ABD, June, 2013

    Source: medicana.com.tr profile page

  38. B2. D.Arslan, H.Bozcuk, S.Gündüz, A.M.Tatlı, M.Uysal, S.S.Goksu, D.Tural, H.S.Coşkun, B.Savaş, The European Cancer Congress 2013 Konferansı Dahilinde, Bildiri Kitapçığındaki "To Assess The Effect Of Regular Excercise, Involvement with Art (Origami) And Group Therapy on Quality of Life, Anxiety, Depression, Patient Satisfactıon and Hope Levels in Patients with Remission Who Had A Variety Of Cancer Diagnoses “Quality of Life Support Program (QoLSP)” Was Developed", 134-0 pp.,Amsterdam, Hollanda, Ekim, 2013

    Source: medicana.com.tr profile page

  39. B3. S.Gunduz, H.S.Coskun, S.Goksu, D.Arslan, A.M.Tatli, M.Uysal, B.Savaş, M.Ozdogan., 2013 ASCO Annual Meeting Konferansı Dahilinde, Bildiri Kitapçığındaki "Can Pet CT Predict Response in Locally Advanced Rectal Cancer Patients Treated with induction Folfox?", 14696-14696 pp., Chicago, ABD, June, 2013

    Source: medicana.com.tr profile page

  40. B4. M.Uysal, H.Bozcuk, S.Goksu, A.M.Tatli, D.Arslan, S.Gunduz, H.S.Coskun, M.Ozdogan, B.Savas,, 2012 ASCO Annual Meeting Konferansı Dahilinde, Bildiri Kitapçığındaki "Proteinuria As A Predictive Factor in Metastatic Colorectal Cancer Patients Treated with Bevacizumab", 14070-0 pp.,Chicago, ABD, June, 2012

    Source: medicana.com.tr profile page

  41. B5. A.M.Tatli, H.S.Coskun, M.Uysal, S.Goksu, D.Arslan, S.Gunduz, M.Ozdogan, H.Bozcuk, B.Savas, 2013 ASCO Annual Meeting Konferansı Dahilinde, Bildiri Kitapçığındaki "Capecitabine Plus Bevacizumab (Cape-Bev) as A Maintenance Treatment After Induction Treatment With Folfiri Plus Bevacizumab (Folfiri-Bev) in Metastatic Colorectal Cancer (MCRC).", 14683-14683 pp.,Chicago, ABD, June, 2013

    Source: medicana.com.tr profile page

  42. B6. M.Uysal, M.Ozdogan, A.Mutlu, S.Testemel, S.Goksu, A.M.Tatli, D.Arslan, S.Gunduz, H.S.Coskun, H.Bozcuk, B.Savas, 2nd Congress Of The Mediterranean Multidisciplinary Oncology Forum Konferansı Dahilinde, Bildiri Kitapçığındaki "Metastatic Malignant Melanoma-Ipilimumab: Treatment Efficacy and Side Effects", 117-117 pp.,İstanbul, Turkey, November, 2011

    Source: medicana.com.tr profile page

  43. B7. M.Uysal, M.Ozdogan, A.Mutlu, S.Testemel, S.Goksu, A.M.Tatli, D.Arslan, S.Gunduz, H.S.Coskun, H.Bozcuk, B.Savas, 2nd Congress Of The Mediterranean Multidisciplinary Oncology Forum Konferansı Dahilinde, Bildiri Kitapçığındaki "Evaluation of The Patients Received Cabazitaxel For Metastatic Prostate Cancer", 116-116 pp.,İstanbul, Türkiye, November, 2011

    Source: medicana.com.tr profile page

  44. B8. M.Uysal, M.Ozdogan, S.Goksu, A.M.Tatli, D.Arslan, S.Gunduz, H.S.Coskun, H.Bozcuk, B.Savas, 2nd Congress Of The Mediterranean Multidisciplinary Oncology Forum Konferansı Dahilinde, Bildiri Kitapçığındaki "Prolonged Progression-Free Survival with Oral Cyclophosphamide and Oral Etoposide at Patients with Ovarian Cancer ", 144-144 pp.,İstanbul, Türkiye, November, 2011

    Source: medicana.com.tr profile page

  45. C1. D. Arslan, A. M. Tatlı, Ü. Üyetürk, ’’Kansere Bağlı Ağrı ve Tedavisi’’, Abant Medical Journal, ’’2’’, 2013, doi: 10.5505/abantmedj.2013.85856

    Source: medicana.com.tr profile page

  46. C2. D.Arslan, A.M.Tatlı, M.Uysal, M.A.Kaplan, "Ekrin porokarsinoma: Olgu sunumu ve literatür taraması", Journal of Clinical and Experimental Investigations , "4", 370-373 pp., 2013, DOI: 10.5799/ahinjs.01.2013.03.0305.

    Source: medicana.com.tr profile page

  47. D1. Ş.Gündüz, D. Arslan, S. S. Göksu, A.M. Tatlı, M. Uysal, H.Ş. Coşkun, H.Bozcuk, H.Mutlu, B. Savaş, 5. Türk Tıbbi Onkoloji Kongresi Konferansı dahilinde, ’’ 5. Türk Tıbbi Onkoloji Kongresi Kongre Kitabı", bildiri kitapçığındaki "Adjuvan Transtuzumab kullanan Her 2 Pozitif Meme Kanserli Hastalarda Hastalıksız Sağkalımı Etkileyen Faktörler", 510 pp.,Antalya, Türkiye, Mart, 2014’

    Source: medicana.com.tr profile page

  48. D2. E. Avşar, D.Arslan, S.Gunduz, M.Uysal, A.M.Tatli, S.S.Goksu, C.İ. Bassorgun, B.Savas, 20. Ulusal Kanser Kongresi konferansı dahilinde , "20. Ulusal Kanser Kongresi", bildiri kitapçığındaki "Testisin Nadir Görülen Tümörü: İnflamatuar Miyofibroblastik Tümörlü Bir Olgu Sunumu", 179-180 pp.,Antalya, Türkiye, Nisan, 2013

    Source: medicana.com.tr profile page

  49. D3. S. Oflaz, A. Merdin, D. Arslan, H.Ş. Coşkun, H.Bozcuk, H.Mutlu, M. Karabulut, 5. Türk Tıbbi Onkoloji Kongresi Konferansı dahilinde, ’’ 5. Türk Tıbbi Onkoloji Kongresi Kongre Kitabı", bildiri kitapçığındaki "Akdeniz Üniversitesi Tıp Fakültesi Hastanesi Kemoterapi Ünitesi: En Çok Kullanılan Kemoterapötik Ajanlar ve Nefrotoksisite", 402 pp.,Antalya, Türkiye, Mart, 2014’

    Source: medicana.com.tr profile page

  50. D4. S. Oflaz, D. Arslan, A. Merdin, H.Ş. Coşkun, H.Bozcuk, H.Mutlu, 5. Türk Tıbbi Onkoloji Kongresi Konferansı dahilinde, ’’ 5. Türk Tıbbi Onkoloji Kongresi Kongre Kitabı", bildiri kitapçığındaki "Onkoloji Eczalığı ve Önemi", 397-98 pp.,Antalya, Türkiye, Mart, 2014’

    Source: medicana.com.tr profile page